PreveCeutical Medical Inc (CSE:PREV) has appointed its chief scientific officer Dr Makarand Jawadekar to the board of directors.
His arrival follows the departure of director and vice president of corporate development Brian Harris, who resigned from his position on Tuesday (October 24).
Jawadekar, who counts pharma giant Pfizer Inc (NYSE:PFE) among his former employers, will continue in his role as SCO as well, PreveCeutical said.
“We are delighted to welcome Dr Jawadekar to PreveCeutical’s board of directors,” said chairman and chief executive Stephen Van Deventer.
“His exceptional knowledge in drug delivery technologies and experience in the pharmaceutical industry will be of tremendous benefit to the company.”
Shares were untraded at C$0.65 on Thursday morning.